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Summary
 
Phosphatidyl choline (PtC)-specific B cells segregate to the B-1 subset, where they comprise
up to 10% of the B-1 repertoire. About half express V
 
H
 
12 and V
 
k
 
4/5H and are restricted in
 
V
 
H
 
CDR3. We have previously reported that anti-PtC V
 
H
 
CDR3 is enriched among V
 
H
 
12-
expressing cells by selective elimination of pre-B cells. We report here a bias for V
 
k
 
4/5H ex-
 
pression among V
 
H
 
12-expressing B cells, even among those that do not bind PtC and are not B-1.
This is due in part to an inability of V
 
H
 
12 to associate with many light (L) chains but must also
be due to a selective advantage in survival or clonal expansion in the periphery for V
 
k
 
4/5H-
expressing cells. Thus, the bias for V
 
k
 
4/5H expression is independent of PtC binding, and, as
segregation to B-1 occurs after Ig gene expression, it precedes segregation to the B-1 subset. In
6-1 mice, splenic B-1 cells reside in follicles but segregate to follicles distinct from those that
contain B-2 cells. These data indicate that selection at multiple developmental checkpoints en-
sures the co-expression of an anti-PtC V
 
H
 
CDR3 and L chain in a high frequency of V
 
H
 
12 B
cells. This focus toward specificity for PtC facilitates the development of a large anti-PtC B-1
repertoire.
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T
 
he B-1 cells comprise a distinct subset of the B cell
repertoire in normal mice. For example, B-1 cells are
the predominant B cell type in the peritoneum, are infre-
quent in the spleen, and are generally absent from lymph
nodes and bone marrow, whereas conventional B-2 cells
are the predominant B cell type in both spleen and lymph
node (1, 2). In addition, whereas most conventional B cells
are small, resting, naive B cells, B-1 cells have characteris-
tics of activated cells; they are larger and more granular (2),
they express activated signal transducer and activator of
transcription 3 (STAT-3) in the peritoneum (3), and in
both the spleen and peritoneum they are resistant to toler-
 
ance induction by anti-Ig (4). They also express V
 
H
 
 and
 
V
 
k
 
 repertoires that differ considerably from those of
conventional B cells (5). These and other differences sug-
gest that conventional and B-1 cells have different roles in
the immune system.
An intriguing feature of B-1 cells is their unusual reper-
toire. High frequencies of B-1 cells are polyreactive and
autoreactive. These include B cells specific for single-
stranded DNA, IgG (rheumatoid factor), and phosphatidyl
choline (PtC),
 
1
 
 a common membrane phospholipid (6–9),
all of which are rare among B-2 cells (8, 10). The B-1 sub-
set also includes B cells specific for bacterial carbohydrate
antigens and phosphoryl choline (11, 12), prompting sug-
gestions that B-1 cells are involved in T cell–independent
responses to common bacterial antigens.
How B cells of certain specificities segregate to one sub-
set or the other is unknown but is likely to be a function of
B-1 and B-2 cell origins. One hypothesis (the lineage hy-
pothesis) to explain B-1 and B-2 cell origins posits that
they derive from stem cells committed to producing only B
cells of one subset or the other (13–15). It is based prima-
rily on cell transfer experiments indicating that bone mar-
row and fetal liver are differentially able to restore the B-1
cell subset in lethally irradiated mice. We and others (16,
17) have proposed the induced differentiation hypothesis
that posits a single B cell lineage and that, upon exposure to
certain antigens, B-2 cells differentiate to B-1 cells. To re-
flect the ability of B-2 cells to differentiate to B-1, the
former have been referred to as B-0. Thus, B-2 cells of the
lineage hypothesis and B-0 cells of the induced differentia-
tion hypothesis are equivalent and in this report are re-
ferred to as B-0. This hypothesis was prompted by the
observation that anti-IgM and IL-6 can induce splenic con-
ventional B cells to acquire a B-1 cell phenotype in vitro
(16). It is supported by our observations using transgenic
(Tg) mice that PtC-specific B cells segregate to the B-1
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; PALS, periarteriolar
lymphatic sheaths; PtC, phosphatidyl choline; Tg, transgenic. 
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subset after Ig gene rearrangement and by the finding that
these Tg B cells are B-0 under circumstances in which signals
initiated by the B cell receptor (BCR) are blocked (10, 18).
To understand segregation to the B-1 subset, we have
followed the differentiation of PtC-specific B cells, a popu-
lation that accounts for 5–10% of the normal B-1 reper-
toire (8). They express predominantly one of two V
 
H
 
/V
 
k
 
combinations, V
 
H
 
12/V
 
k
 
4/5H and V
 
H
 
11/V
 
k
 
9, and are re-
stricted in V
 
H
 
 CDR3 (19). Among V
 
H
 
12 anti-PtC B cells,
the CDR3 is made up of 10 amino acids with an invariant
glycine in the fourth position and a tyrosine encoded by
J
 
H
 
1 in the fifth position, a motif designated 10/G4. These
restrictions indicate that antigen-driven clonal expansion is
responsible for the large number of B-1 cells of this speci-
ficity in normal mice (8).
The 10/G4 CDR3 is enriched at the pre-B cell stage
(20). This occurs by the elimination of most V
 
H
 
12 pre-BII
cells that do not have a 10/G4 CDR3 sequence (non-10/
G4) during the transition from pre-BI to pre-BII. As this
coincides with the expression of the pre-BCR, we have
proposed a positive selection mechanism to account for this
differential survival. 10/G4 pre-BCRs bind ligand and
transduce a signal to turn off ongoing programmed cell
death, whereas non-10/G4 pre-B cells are unable to bind
ligand and fail to turn off programmed cell death. What-
ever the mechanism, selection at the pre-B cell stage en-
riches for 10/G4 B cells that will ultimately contribute to
the PtC-specific B-1 repertoire.
We demonstrate in this report that splenic V
 
H
 
12 B cells
expressing V
 
k
 
4/5H are enriched, even among non-PtC–
binding V
 
H
 
12 B cells. This, together with the enrichment
for 10/G4 V
 
H
 
12 rearrangements at the pre-BII cell stage,
ensures that a high proportion of V
 
H
 
12-expressing B cells
bind PtC and differentiate to B-1. We suggest that this un-
precedented developmental selection has evolved to ensure
that a high percentage of V
 
H
 
12 B cells bind PtC and are
present in every individual, underscoring their importance
to the survival of the individual.
 
Materials and Methods
 
Mice.
 
V
 
H
 
12 Tg mice (6-1) were previously generated (10)
and maintained in our pathogen-free animal facility at the Uni-
versity of North Carolina (UNC) by backcrossing to C.B17
mice. Offspring carrying the transgene were identified by PCR
of tail genomic DNA as previously described (10). Mice ho-
mozygous for the deletion of the 
 
k
 
 locus were provided by Gen-
Pharm International (21) and bred to 6-1 mice to obtain 6-1/
 
k
 
2
 
/
 
2
 
mice.
 
Sorting and V
 
k
 
 Repertoire Determination.
 
The 
 
k
 
 L chain reper-
toire was determined for subsets of PtC-binding and -nonbinding
lymphocytes from 6-1 mice. Splenic lymphocytes were stained
with anti-B220–PE antibodies and liposome-encapsulated car-
boxyfluorescein, and the B220
 
1
 
 cells that were PtC
 
bri
 
, PtC
 
int
 
, and
PtC
 
neg
 
 were sorted on a MoFlo high speed sorter (Cytomation,
Inc.). Total RNA was extracted from 
 
z
 
10
 
6
 
 sorted cells using
TRIzol (Life Technologies, Inc.) according to the manufacturer’s
protocol. The RNA was subjected to RT-PCR using 5
 
9
 
 RACE
(rapid amplification of cDNA ends; version 2.0; Life Technolo-
 
gies, Inc.). For reverse transcription, we used a GSP1 custom
primer, GGGGTAGAAGTTGTT, that anneals to the C
 
k
 
 en-
coding sequence 
 
z
 
80 bases 3
 
9
 
 of the J–C
 
k
 
 junction. For the
PCR, we used the 5
 
9
 
 RACE anchor primer and a custom GSP2
primer, CAUCAUCAUCAUCTGAGGCACCTCCAGATG-
TTA, that anneals to a region of the C
 
k
 
 sequence 50 bases from
the J–C junction. 40 cycles of amplification were performed. The
conditions for the PCR were 94
 
8
 
C for 1 min, annealing at 55
 
8
 
C
for 1 min, and primer extension at 72
 
8
 
C for 1.5 min. The final
extension was at 72
 
8
 
C for 5 min. The amplification product
was  cloned into the pAMP1 vector using the CloneAmp
 
®
 
pAMP1system (Life Technologies, Inc.) according to the manu-
facturer’s protocol. Plasmid DNA was isolated from randomly
picked colonies and sequenced using the Sequenase II kit (Strat-
agene, Inc.) or the UNC Automated DNA Sequence Facility.
The oligonucleotide used to prime sequencing was GGCTCT-
GACTAGATCTGCAAGAGAT. Sequence comparisons and
analysis used DNASIS 2.5 software and the BLAST (Basic Local
Alignment Search Tool) sequence search facility (GenBank).
For the sorting of B cells for adoptive transfer, spleen cells
from 6-1 mice were stained for B220 and CD23 and sorted for
B220
 
1
 
CD23
 
2 
 
cells. Sorting was done using the MoFlo high
speed sorter (Cytomation, Inc.). Approximately 3–5 
 
3
 
 10
 
6
 
 cells
were transferred intravenously to unirradiated C.B17 mice.
Spleens were taken after 24 h and after 7 d for sectioning and
analysis by immunofluorescence microscopy as described below.
 
Flow Cytometry and Immunofluorescence Microscopy.
 
The anti-
bodies used for flow cytometry and the method for staining were
as previously described (10, 18). The cells were analyzed using a
FACScan™ (Becton Dickinson) with hardware interface and ac-
quisition and analysis software from Cytomation, Inc. All data
represent cells that fall within the lymphocyte gate determined by
forward and 90
 
8
 
 light scatter. All contour plots are 5% probability.
For immunofluorescence microscopy, spleens were imbedded
in TBS compound (Triangle Biomedical Sciences) and flash fro-
zen in liquid nitrogen and 2-methylbutane. Frozen sections were
air dried and fixed in acetone for 2 min and subsequently washed
with 1
 
3
 
 PBS. Blocking was performed for 1 h at room tempera-
ture with normal rat and mouse serum. The first step staining was
performed for 1 h at room temperature with anti-IgM
 
a 
 
(or
-IgM
 
b
 
)–FITC and anti-CD23–biotin. After incubation, sections
were washed two times with 1
 
3
 
 PBS and then stained with anti-
CD3–PE and streptavidin–Cy5, washed with PBS, and mounted
in Fluoromount G (Southern Biotechnology Associates, Inc.).
Slides were examined with a Leica TCS-NT confocal laser scan-
ning microscope (Leica Inc.) equipped with argon and helium-
neon lasers. Photomultiplier tube voltages and laser powers were
set to eliminate the background signal given by the IgG isotype
and streptavidin–Cy5-only controls. Images from three different
fluorescent channels were recorded simultaneously. Image pro-
cessing was performed with the Leica TCS-NT proprietary soft-
ware and Adobe Photoshop (Adobe Systems, Inc.).
 
H and L Chain Association.
 
Gene transfections were done as
described previously (22). In brief, 
 
m
 
 expression vectors were
transfected into L chain–only hybridoma cell lines. These hy-
bridoma lines were J558L (
 
l
 
), 4A9 (V
 
k
 
RF), 2-12 (V
 
k
 
31), 1E5
(V
 
k
 
8), D35.2 (V
 
k
 
8), and CH12.2b4 (V
 
k
 
10) (22). An H chain
loss mutant of the anti-Sm hybridoma 1-8C2 (23), provided by
M. Borrero (UNC), was used to test association with V
 
k
 
1A L
chains. V
 
k
 
4/5H and V
 
k
 
21C L chain–only cell lines were not
available. Therefore, we cotransfected into P3-X63-Ag8.653
myeloma cells with the 10/G4 or 2-12 expression constructs with
L chain expression vectors containing V
 
k
 
4/5H or V
 
k
 
21C rear- 
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Figure 1. The phenotype of
PtCneg, PtCint, and PtCbri cells of
6-1 mice. 6-1 splenic B cells were
stained for liposome binding,
B220, and CD23, CD5, CD43,
or IgMa. Shown is the histogram
for B220 versus liposomes, and
the gates used to identify the
three populations of B cells are
shown at the top of the figure. In
columns A, B, and C is the phe-
notypic analysis of PtCneg, PtCint,
and PtCbri cells, respectively. For
each mouse, 7–8 3 107 spleen
cells were stained and 50,000 cells
per sample were acquired on the
flow cytometer. 
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rangements as described (22). To test whether a complete Ig mol-
ecule was formed, supernatant was subjected to ELISA using
microtiter plates coated with polyclonal goat anti–mouse 
 
m
 
(Southern Biotechnology Associates, Inc.) and alkaline phos-
phatase–labeled polyclonal goat anti–mouse 
 
k
 
 (Southern Bio-
technology Associates, Inc.) to develop the reaction. In those
cases where Ig secretion was not detected, the production of
H and L chains was confirmed by ELISA using cell lysates and
the polyclonal goat anti–mouse 
 
m
 
– or polyclonal goat anti–
mouse 
 
k
 
-coated plates as above. The former were developed
with phosphatase-labeled polyclonal goat anti–mouse 
 
m
 
 to de-
tect H chain, and the latter were developed with phosphatase-
labeled goat anti–mouse 
 
k
 
 to detect L chain. OD readings were
determined with an automated plate reader (Emax; Molecular
Devices).
 
Results
 
The Phenotype of the Splenic B Cell Subpopulations in 6-1
Mice.
 
We have previously described the PtC-specific B-1
cells of V
 
H
 
12 Tg (6-1) mice (10). As a result of antigen-
driven clonal expansion, the number of these cells is con-
siderable, comprising 60–90% of the splenic B cell popula-
tion in adults (10). They can be detected by staining with a
liposome probe that contains PtC as a membrane compo-
nent and that encapsulates carboxyfluorescein (8). These
cells stain brightly with liposomes (PtC
 
bri
 
) and, as described
 
previously (10, 18), are B220
 
low
 
IgM
 
high
 
CD23
 
2
 
, and most
express CD5 and CD43 (Fig. 1).
Based on the liposome staining, there are at least two
other B cell populations in 6-1 mice (Fig. 1), cells that do
not stain with liposomes (PtC
 
neg
 
) and cells that have an in-
termediate level of liposome staining (PtC
 
int
 
). The PtC
 
neg
 
and PtC
 
int
 
 populations are about equal in size and together
account for 10–30% of splenic B cells. Most cells of both
populations are B-0, i.e., CD23
 
1
 
CD5
 
2
 
CD43
 
2
 
B220
 
high
 
(Fig. 1). Some cells of both populations are CD232. This
population is likely to include immature B cells but may
also include B-1 cells, as the PtCneg and PtCint populations
appear to include cells that express CD43. Inasmuch as
there are essentially no 6-1 splenic B cells that express IgMb
(10), we attribute the differences in liposome binding and
segregation to the B-0 or B-1 subsets to differences in the L
chain.
L Chain Gene Use by 6-1 Splenic B Cells. The Vk rep-
ertoire of 6-1 splenic B cells was determined independently
for sorted PtCneg, PtCint, and PtCbri B cell populations.
mRNA was isolated from each population and used in a
k-specific RT-PCR. cDNA clones were generated, and
randomly selected clones were sequenced to identify the
Vk and Jk gene segments. Sequence analysis indicates re-
markable similarities in the Vk repertoire among these
populations.
Figure 2. Vk use by PtCneg, Pt-
Cint, and PtCbri cells from 6-1
mice. Approximately 106 splenic B
cells were sorted from 6-1 mice as
indicated in the histogram (B220
versus liposomes) and mRNA iso-
lated separately from each subset.
RT-PCR was performed to am-
plify the expressed rearranged Vk
genes and individual clones se-
quenced. The percent of clones
corresponding to the indicated Vk
groups is indicated in the bar
graphs at the top, and the total
number of sequences is given in
parentheses at the top of each
graph. (A) Vk use by PtCneg B
cells. (B) The breakdown of Vk4/5 gene use by PtCneg cells into Vk4/5H and other members of this family shown in A. The total numbers of sequences
corresponding to the Vk4/5 and non-Vk4/5 subsets are given in parentheses. (C) Vk use by PtCint B cells. (D) Vk use by PtCbri B-1 cells. All Vk iden-
tifications are Vk groups except Vk4/5H, which denotes a specific Vk4/5 gene.907 Tatu et al.
All but two of the cDNA clones from the PtCbri B-1
cells and three of the clones from the PtCint B-0 cells are of
the identical Vk gene (designated Vk4/5H; reference 24)
(Fig. 2, C and D). This is the same Vk gene expressed by
PtC-specific lymphomas and peritoneal B-1 cell hybridomas
(19). In contrast, the Vk genes cloned from the PtCneg pop-
ulation are more heterogeneous (Fig. 2 A). 57% of the rep-
ertoire consists of non-Vk4/5 genes from 12 Vk groups.
The remaining 43% are Vk4/5 genes, and of these, 68%
are Vk4/5H (Fig. 2 B). Combining the PtCneg and PtCint
B-0 populations, we estimate that 66% of B-0 cells use a
member of the Vk4/5 group and 59% use Vk4/5H. Such a
bias among B-0 cells is not evident in non-Tg littermate
mice, as only two (6%) of the B-0 sequences express a
Vk4/5 gene, neither of which are Vk4/5H (Fig. 3). Thus,
Vk4/5H dominates both the B-0 (PtCneg and PtCint) and
B-1 subsets in 6-1 mice as a consequence of VH12 expres-
sion.
These three populations of B cells in 6-1 mice are dis-
tinct in Jk use. The PtCbri B-1 cells use predominantly Jk2
and Jk4 (Fig. 4 A), as is true of PtC-specific lymphomas
and hybridomas (19). This bias undoubtedly reflects selec-
tion for this specificity and expansion in the B-1 subset. Pt-
Cint B-0 cells use Jk2 almost exclusively. We attribute this
to the fact that a tyrosine at the Vk–Jk junction, which
is encoded by Jk2, results in PtCint binding. Vk4/5H-
expressing PtCneg B-0 cells use Jk2, -4, and -5, with Jk5
used at almost twice the frequency as Jk2 (Fig. 4 A). No-
tably, almost none of the Vk4/5H-expressing B cells
from any of these populations use Jk1. This contrasts with
the predominant use of Jk1 and Jk2 by non-Tg B-0 cells
(Fig. 4 C) and even by non-Vk4/5 genes from the PtCneg
B-0 cells (Fig. 4 B).
Vk4/5H L Chains Segregate According to the Vk–Jk Junc-
tional Sequence. The Vk4/5H L chains of each population
have a characteristic CDR3 sequence. Most (67%) of the
Vk4/5H rearrangements from PtCbri B-1 cells encode a
charged amino acid (primarily arginine) at the Vk–Jk junc-
Figure 3. Vk use by B-0 cells from non-Tg 6-1 littermates.
CD231B2201 cells were sorted as indicated by the gates shown in the
histogram. As for the analysis in Fig. 2, mRNA was isolated from z106
sorted cells for RT-PCR of expressed Vk genes. Individual clones were
sequenced and the Vk groups identified. The representation of individual
Vk groups is presented as the percentage of total (32) Vk sequences de-
termined.
Figure 4. Jk use by 6-1 and non-Tg littermate mice. (A) Jk use by
Vk4/5H rearrangements from the PtCneg, PtCint, and PtCbri populations
of 6-1 mice. (B) Jk use by non-Vk4/5 rearrangements from the PtCneg
population of 6-1 mice. (C) Jk use by B-0 (CD231B2201) cells of non-
Tg littermates. The total numbers of sequences analyzed in each group
are given in Figs. 2 and 3.908 VH12 B Cell Differentiation Is Focused toward a Single Specificity
tion, position 96 (R96) (25), although several have the
nonpolar residues leucine and phenylalanine at this position
(Fig. 5). PtC-specific hybridoma and lymphoma antibodies
have R96 or L96 (19), confirming that anti-PtC B cells use
these junctions.
PtCint rearrangements are the most homogeneous in
their encoded CDR3. Nearly all (z90%) encode Y96. Jk2
is the only Jk that encodes Y96. That this residue can con-
fer binding to PtC is indicated by the anti-PtC lymphoma
CH32 that has Y96 (19). The presence of Y96, along with
the lower IgM levels inherent to B-0 cells, offers an expla-
nation for the weak liposome staining by these cells.
The non-Vk4/5H CDR3 sequences of the PtCneg pop-
ulation are quite heterogeneous in length and sequence
(data not shown), reflecting the fact that most of the L
chain CDR3 is encoded by Vk. The CDR3 regions of
Vk4/5H L chains commonly have a nonpolar, noncharged
amino acid at position 96 and in some cases are one or two
amino acids shorter than the majority of those in the PtCint
and PtCbri populations.
Paradoxically, many Vk4/5H junctional sequences from
PtCneg cells are identical to sequences from PtCbri cells.
Four sequences encode L96 (and are nine amino acids in
length), seven encode F96, and four encode R96. The
presence of rearrangements compatible with PtC binding
in this population are unlikely to be due to a contamination
from other populations during the sort for the following
reasons: sort contamination could come from two sources,
the inability to resolve cells from neighboring populations
and machine error, in which an incorrect cell not necessar-
ily from a neighboring population is sorted. In the case of
the former, PtCint cells would most likely contaminate
PtCneg cells. But this is not the case, as the potential con-
taminants in the PtCneg population do not encode Y96. In
the case of machine error, the most common contaminant
would be from the PtCbri population, as it is the largest
population. We rule this out as an explanation for two rea-
sons. First, by this scenario, both the PtCneg and PtCint pop-
ulations should be contaminated with PtCbri cells, but the
PtCint population is almost completely lacking in sequences
that could derive from the PtCbri population. Second, the
potential PtC-specific sequences in the PtCneg population
are not representative of the PtCbri population; the former
are predominantly L96 and F96, whereas the latter are
predominantly R96. Thus, the potential PtC-specific se-
quences in the PtCneg population are not contaminants. We
calculate from these data that z18% of the PtCneg reper-
toire, which would amount to 12% of the total B-0 reper-
toire, could be PtC binding.
The Expressed Vk Repertoire Is Limited by the Inability of the
VH12 H Chain to Pair with Many L Chains. One possible
explanation for the restricted Vk repertoire expressed by
VH12 B cells is that VH12 is unable to associate with all L
chains. To test this possibility, we transfected a 10/G4
VH12–D–JH1 expression construct into several L chain–
only-expressing cell lines, or cotransfected it with different
L chain expression constructs into a nonexpressing cell line,
and assayed for secretion of IgM. This rearrangement is
identical to that used to generate 6-1 mice. As shown in
Table I, we were unable to detect secreted antibody with
l1 and 5 of the 8 k chains. In those cases in which secreted
Figure 5. CDR3 sequences of Vk4/5H rearrangements from PtCneg,
PtCint, and PtCbri populations from 6-1 mice. The PtCneg sequences are
presented as two groups. The top group is sequences from Vk4/5H rear-
rangements, and the bottom group is from other Vk4/5 gene rearrange-
ments (non-H). The sequences from non-Vk4/5 are quite diverse and
not shown. Arrow indicates position 96 at the Vk–Jk junction.
Table I. VH12 Antibody Secretion
VH12 2-12H*
l1— 1
VkRF — 1
Vk4/5H 11
Vk31 — 1
Vk8— 1
Vk8— 1
Vk1A 11
Vk10 11
Vk21C — 1
Allotype-specific ELISAs were performed on tissue culture supernatant.
Negative values were less than four times the background OD reading,
and in all cases, cytoplasmic m and L chains were detected at levels sim-
ilar to those of Vk4/5H transfectants. Positive values were 10–30 times
background OD.
*The 2-12 H chain is a J558 H chain cloned from an anti-Sm hy-
bridoma of MRL/lpr origin and expressed as a m protein (51).909 Tatu et al.
antibody was not detected, we could detect cytoplasmic H
and L chains. Thus, most L chains failed to associate with
VH12 and were considered nonpermissive.
The inability of VH12 to associate with l1 chains was
confirmed in vivo by generating 6-1 mice that lacked an
intact k locus (6-1/k2/2). The B cells in these mice can
only use l chains. As seen in Fig. 6, B cells are rare in
both the spleens and bone marrow of these mice, indicat-
ing that l1 is nonpermissive in vivo, as are probably most
other l chains, leading to cell death in the bone marrow.
The few B cells present in the spleen use l L chains and ap-
pear to be immature, i.e., CD232CD52CD432 (data not
shown). Thus, the limited ability of VH12 to associate with
L chains affects B cell production.
B-1 Cells Reside in Splenic Follicles in 6-1 Mice. 6-1 B-0
and B-1 cells are distinct in specificity and Vk gene use. To
determine whether there is also a histological distinction
between B-0 and B-1 cells within the spleen, we prepared
splenic sections from 6-1 and control mice for histological
comparison. Spleen morphology in 6-1 mice, as shown by
hematoxylin and eosin staining, does not appear to be dif-
ferent from non-Tg control littermates (data not shown).
In the white pulp, follicular structures are associated with
periarteriolar lymphatic sheaths (PALS) and are separated
from the red pulp by lymphatic sinuses. Considering that
60–70% of the splenic B cells in 6-1 mice are B-1, it is
likely that most if not all B-1 cells are in follicles.
To determine if B-1 cells occupy splenic follicles, we
analyzed spleen sections from 6-1 and non-Tg littermate
mice by confocal scanning laser microscopy. Sections were
stained with antibodies specific for IgMa or IgMb and CD3
to identify B and T cells, respectively. To discriminate be-
tween B-0 and B-1 cells, we used antibodies to CD23, as
CD23 is present on B-0 cells but not B-1 cells. As can be
seen in Fig. 7 B, 6-1 mice have T cell–rich PALS that are
adjacent to B cell–rich follicles. In addition, these follicles
have identifiable marginal zones. Most follicles have B cells
that do not stain for CD23 (Fig. 7 B), indicating that they
contain B-1 cells, whereas follicular B cells from control
non-Tg spleen sections stained simultaneously demonstrate
unambiguous expression of CD23 (Fig. 7 A). Thus, B-1
cells occupy splenic follicles in 6-1 mice. CD231 B-0 cells
can be seen in splenic sections of 6-1 mice, but, surpris-
ingly, they are concentrated to a subset of follicles rather
than intermixed with B-1 cells in all follicles (Fig. 7 C).
The ability of B cells to occupy follicles can be affected
by the presence of B cells of diverse specificity (26). To de-
termine whether PtC-specific B-1 cells enter follicles in the
presence of a majority of heterogeneous B-0 cells, we
adoptively transferred sorted B2201CD232 B-1 cells from
6-1 mice to non-Tg littermates. At 24 h and 7 d after trans-
fer, mice were killed and spleens taken for histological and
flow cytometry analyses. At the time mice were killed, es-
sentially all of the recovered transferred cells were PtCbri
B-1 cells (CD232CD51CD431) (data not shown). As can
be seen in Fig. 7, D and E, IgMa B cells are visible in folli-
cles and PALS at both time points. On day 7, numerous
IgMa bright cells showing cytoplasmic IgM staining are
present in the red pulp (Fig. 7 E). Similar cells are seen in
6-1 mice (Fig. 7, B and C). These cells were not seen at
24 h, suggesting that some B-1 cells have differentiated to
plasmablasts by 7 d after transfer and have migrated to the
red pulp. Many of these cells are present in clusters of two
to five cells (Fig. 7 F), suggesting recent cell division in the
red pulp.
Discussion
The role played by the Ig receptor specificity in the in-
duction of the B cell developmental program is a well es-
tablished immunological paradigm. Our data show here
that the specificity of the cell surface Ig receptor is not only
important in the developmental steps taken among con-
ventional B-0 cells but also in the segregation of cells to the
B-0 and B-1 subsets.
Segregation to B-1. Our previous analysis of anti-PtC
Tg mice supports the idea of an antigen-driven differentia-
tion of cells from B-0 to B-1. This was suggested by the
observation that segregation of PtC-specific B cells to the
B-1 subset is intact in 6-1 mice and in 6-1/Vk4/5 double-
Tg mice in which essentially all developing B cells are PtC
specific (10). These data argue that the mechanism of seg-
regation operates after Ig gene rearrangement. The differ-
entiation of B-1 cells was more directly addressed by com-
bining the VH12 and Vk4 transgenes with the xid mutation
(20). The xid mutation is a loss of function mutation in the
gene for Bruton’s tyrosine kinase (27–30) that causes a dis-
ruption in BCR signaling. Among other deficiencies, xid
mice have few B-1 cells (1). VH12/Vk4 double-Tg mice
with the xid mutation exhibit a significant deficiency in B-1
cell development as expected (20). However, the majority
of splenic PtC-specific B cells are B-0, not B-1, revealing
the existence of a differentiative pathway from B-0 to B-1
that is dependent on signals initiated by the BCR. We have
Figure 6. FACS™ analysis of spleen and bone marrow cells from 6-1/
k2/2 mice. The B cell populations of 6-1/k2/2 (bold line) and 6-1 (dot-
ted line) spleen and bone marrow were compared using the pan-B cell
marker CD19. 910 VH12 B Cell Differentiation Is Focused toward a Single Specificity
Figure 7. Histological analyses of B-1 cells in 6-1 mice. All photographs are of stains using anti-IgMa–FITC (green) (except A, which uses IgMb–
FITC), anti-CD3-PE (red), and anti-CD23–streptavidin–Cy5 (blue) as described in Materials and Methods. (A) Non-Tg littermate follicle and PALS;
(B and C) 6-1 follicles and PALS; (D and E) littermate follicles 24 h or 7 d, respectively, after transfer of 7 3 106 6-1 B-1 cells; (F and inset) isolation on
IgMa cells in the red pulp 7 d after transfer. Magnification is 200 except for the inset in F, which is at 2,000.911 Tatu et al.
recently demonstrated this differentiative pathway in anti-
PtC Tg, non-xid mice by manipulation of PtC-specific
cells that are at intermediate differentiative stages in this
pathway (Arnold, L.W., S.K. McCray, C. Tatu, and S.H.
Clarke, manuscript submitted for publication).
Viewed in this context, we interpret the segregation of
6-1 B cells to be based on their ability to bind PtC. All
newly differentiated B cells from the adult bone marrow
are B-0. However, those that bind PtC with high affinity
(PtCbri) are induced to become B-1, whereas those that bind
PtC weakly or not at all (PtCint and PtCneg, respectively) are
not signaled sufficiently and remain B-0. Among 6-1 cells
that express a 10/G4 VH12 H chain and Vk4/5H L chain,
the ability to bind PtC is dependent on the amino acid at the
Vk–Jk junction, position 96. These data therefore disprove
any notion that VH or Vk gene expression plays a role in seg-
regation and demonstrate that the level of PtC binding de-
termines differentiation to B-1. This is further evidence that
segregation to B-1 occurs after Ig gene rearrangement.
An unexpected finding from this analysis was the pres-
ence of Vk4/5H rearrangements in the PtCneg population
that are identical to some in the PtCbri B-1 population. Be-
cause IgM2 cells exist among the PtCneg population, it is
plausible that these rearrangements derive from PtCbri cells
that have lost surface IgM (Fig. 1) and are therefore sorted
with the PtCneg population. IgM2 cells are z20% of the
PtCneg population, similar to the 18% estimate made from
the sequence analysis. Loss of surface Ig can occur in B cells
undergoing cell division. For example, rapidly dividing
germinal center centroblasts do not express surface Ig (31).
A similar downregulation may occur in dividing B-1 cells
or in cells differentiating to B-1. Alternatively, these cells
could be plasmablasts that have lost surface IgM, such as the
cells seen in the red pulp in 6-1 mice and in normal mice
after adoptive transfer of PtCbri B-1 cells (Fig. 7).
Upon differentiation in 6-1 mice, PtC-specific B-1 cells
reside in splenic follicles and in fact occupy most splenic
follicles, as they are in the majority. However, it is interest-
ing that B-0 and B-1 cells segregate to different follicles.
Whether this occurs in non-Tg mice is unknown. B-1 cells
are not excluded from entry into a follicle composed
mostly of B-0 cells as are other autoreactive B cells (26), in-
dicating that exclusion from B-0 follicles is not the basis for
segregation. Perhaps B-0 cells are excluded from B-1 folli-
cles, or this segregation reflects competition between B-0
and B-1 cells during the time of follicle formation.
Some adoptively transferred B-1 cells have moved into
the red pulp by 7 d after transfer and differentiated to plas-
mablasts. That not all B-1 cells differentiate to plasmablasts
in 6-1 mice or in non-Tg mice that have received B-1 cell
transfers suggests that migration to the red pulp and differ-
entiation to a plasmablast are regulated independently from
differentiation to B-1, although both presumably require
antigen. This transition could be a controlling checkpoint
for the secretion of natural IgM, as B-1 cells are considered
the major source of this antibody (1, 9, 12).
The Bias in Vk Repertoire Precedes Segregation to B-1 and Is
Independent of PtC Binding. Although it was anticipated
that Vk4/5H would dominate the B-1 PtCbri population,
the dominance of Vk4/5H in the B-0 subset was a surprise.
As many as 59% of B-0 cells in these mice use Vk4/5H.
Even though some Vk4/5H-expressing B cells may be
PtC-specific B-1 cells that have lost surface Ig, this only de-
creases the proportion to 51%. Thus, extraordinarily high
frequencies of B-0 cells express Vk4/5H, indicating that
the bias in Vk expression is independent of PtC binding.
As the segregation to B-1 occurs after expression of H and
L chains (10), this bias must also precede segregation to the
B-1 subset.
The inability of VH12 to associate with many L chains is
no doubt a contributing factor, as it limits Vk repertoire
expressed by VH12 B cells. The fact that most L chains are
nonpermissive in 6-1 mice (Fig. 6), provides an explanation
for why 6-1 mice develop 10% as many B-0 cells as non-Tg
littermates (18). The basis for the inability of VH12 to asso-
ciate with most k and l chains is unknown. It is well es-
tablished that V region structures influence L chain asso-
ciation (32–34) and that this involves both framework
regions and CDRs (32–36). A second VH12 H chain, dif-
fering only in CDR3 from the 10/G4 VH12 used here, is
similarly deficient in ability to associate with L chains (Ye,
J., H. Wang, L.W. Arnold, and S.H. Clarke, manuscript in
preparation), implicating the VH-encoded segment rather
than CDR3 in this inability. As this VH is unmutated, this
characteristic must be evolutionarily selected, possibly to
limit the diversity of VH12 B cells.
Although the large number of nonpermissive L chains
would account for the small B-0 population in 6-1 mice, it
would not by itself account for the dominance of Vk4/5H
in B-0, as there are multiple permissive L chains (Fig. 2 A
and Table I). Favor for Vk4/5H could be achieved by a
higher rearrangement frequency for this gene than for oth-
ers. Although there is evidence that Vk4/5 genes prefer-
entially rearrange (37), there is no apparent Vk4/5 bias
among B-0 cells from non-Tg littermates. We therefore
propose that VH12 B cells that express Vk4/5H are favored
over others for survival or clonal expansion. In this context,
we have recently observed that the B cells in 6-1/Vk1A
double-Tg mice are predominantly immature, suggesting
that not all VH12 B cells expressing a permissive L chain
have an equal ability to contribute to the long-lived mature
repertoire. We are currently testing this hypothesis.
The pattern of Jk use among B-0 cells in 6-1 mice pro-
vides clues to the mechanism behind Vk4/5H dominance.
In normal mice, z80% of Vk rearrangements in B-0 cells
are to Jk1 and Jk2 (38), as seen in our non-Tg control mice
(Fig. 4 C). But 6-1 B-0 cells show a different pattern of Jk
use depending on whether or not they express Vk4/5H.
Vk4/5H rearrangements are skewed to downstream Jk
gene segments and are rarely to Jk1 (Fig. 4 A). In contrast,
non-Vk4/5 rearrangements are significantly less biased to
downstream Jks, and z35% are to Jk1 (Fig. 4 B). The ab-
sence of rearrangements to Jk1 in Vk4/5H-expressing B-0
cells could be due to an inability of this gene to efficiently
rearrange to Jk1. Although we cannot exclude this possibil-
ity, we think it unlikely because we identified several rear-912 VH12 B Cell Differentiation Is Focused toward a Single Specificity
rangements to Jk1 (Fig. 4), and we know of no precedent
for such a molecular defect. An alternative possibility is that
Vk4/5H-Jk1 rearrangements cannot associate with VH12.
Junctional amino acids affect association (35), and W96,
unique to Jk1, is not seen among the few Vk4/5H-Jk1 re-
arrangements identified and is present in only one Vk4/5
(non-H) rearrangement (Fig. 5). However, rearrangements
that delete the first codon of Jk1 are common and would
yield Jk regions identical to those encoded by Jk2, as Jk1
and Jk2 are identical in amino acid sequence after the first
amino acid. In fact, many of the rearrangements with R96
are the result of a rearrangement to Jk2 that includes the
last codon of Vk4/5H and deletes the first codon of Jk2
(19). The identical L chain could be generated by rear-
rangement to Jk1. Thus, Jk1 use should be seen among the
PtCbri B-1 population, if not the PtCneg B-0 population,
even if W96 disrupts association with VH12. That it is not
argues against the idea that Jk1 rearrangements are not rep-
resented because they disrupt association with VH12.
The more likely explanation is that Vk4/5H expression
is the result of secondary rearrangement. The occurrence of
secondary rearrangement to delete a primary rearrangement
is well established and would result in a bias for the use of
downstream Jk gene segments (39–42). Secondary rear-
rangement could occur in VH12 pre-B cells to replace pri-
mary rearrangements that encode nonpermissive L chains.
As a majority of L chains appear to be nonpermissive with
VH12 H chains, secondary rearrangement may occur in a
high proportion of these cells. Unless replaced, expression
of a nonpermissive L chain will result in cell death, as seen
in 6-1/k2/2 mice (Fig. 6). A prediction of this hypothesis is
that nonpermissive L chains are unable to mediate allelic
exclusion. This was argued by others based on analyses of
murine plasmacytomas that produce multiple L chains, of
which only one was able to pair with the expressed H
chain (43, 44), and based on an analysis of k Tg mice (45).
We therefore suggest that Vk4/5H rearrangements are pre-
dominantly secondary to primary rearrangements that en-
code nonpermissive L chains. Thus, secondary rearrange-
ment probably contributes to the dominance of Vk4/5H
by VH12 B-0 cells. As secondary rearrangement occurs in
the bone marrow before commitment to B-1, the anti-PtC
B-1 repertoire must be dependent on secondary Vk4/5H
rearrangements as well, accounting for the absence of Jk1
rearrangements from the B-1 repertoire. Why Vk4/5H re-
arrangements are more skewed to downstream Jks than
non-Vk4/5 rearrangements, implying that the former are
more often secondary rearrangements than the latter, is still
unresolved. This may be related to the suspected advantage
that Vk4/5H-expressing B cells have in entry into the
long-lived mature B-0 repertoire and may involve addi-
tional Vk rearrangement in transition to a mature B cell.
We are currently testing this possibility.
Selection at Multiple Checkpoints Focuses the Specificity of
VH12 B Cells to PtC. These data reveal yet another check-
point in B cell development that imposes a stringent limita-
tion on VH12 B cell repertoire diversity. The first occurs at
the transition from pre-BI to pre-BII, where the length and
sequence of VH12 CDR3 are selected (20). Pre-B cells
with 10/G4 rearrangements support pre-B cell differentia-
tion, whereas most non-10/G4 rearrangements cannot, re-
sulting in an enrichment of pre-B cells with 10/G4 rear-
rangements (20). The data reported here document a
checkpoint after L chain gene rearrangement, during the
transition to an immature B cell. The Vk repertoire is lim-
ited at this stage due to an inability of most L chains to as-
sociate with VH12, resulting in a much smaller than normal
B-0 subset. Because this cannot account for the dominance
of Vk4/5H among B-0 cells, we suggest an additional se-
lective mechanism operating at a later stage that favors
VH12/Vk4/5H-expressing cells, possibly during the transi-
tion from an immature to a mature B cell. This process
generates a pool of B-0 cells from which cells with the
PtCbri phenotype are selected by antigen for entry into the
B-1 repertoire and clonal expansion. As 10/G4 VH12 H
chains and Vk4/5H L chains are critical for the PtCbri phe-
notype, we suggest that there has been evolutionary pres-
sure to develop a VH12 B-0 repertoire enriched in PtCbri
cells. This would promote the production of a large num-
ber of PtC-specific B-1 cells. The evolutionary selection
for the development of anti-PtC B cells complements an
earlier finding by Booker and Haughton (46) that the VH12
and VH11 (also encoding anti-PtC antibodies) genes are
evolutionarily more conserved than other VH genes.
In spite of sustained research efforts, the function of
B-1 lymphocytes remains elusive. Their characterization in
many vertebrate species suggests a strong phylogenetic con-
servation and a fundamental homeostatic or protective role.
A limited repertoire of antigen specificities and the expres-
sion of low-affinity Ig receptors could indicate that these
cells are a “first line” immune defense against bacterial or-
ganisms (47). A recent report by Boes et al. (48) showing
that anti-PtC antibodies are protective in acute peritonitis
provides direct evidence that anti-PtC antibodies are im-
portant in immediate protection against bacterial infections.
Perhaps the physiological target of these antibodies is un-
likely to change over time and is shared by a large number
of organisms, and therefore the development of a response
to this antigen could be evolutionarily selected to provide
immediate protection before a T cell–dependent high-
affinity response can develop. For the same reasons, B-1
cells could also have a role in the “scavenging” of senescent
or apoptotic cells resulting from physiological or pathologi-
cal events; these cells can express self-antigens on their sur-
faces (e.g., PtC, nuclear antigens, DNA) (49, 50), toward
which the B-1 Ig repertoire is oriented. As these autoanti-
gens do not vary their epitopes in time, mechanisms to
eliminate them could also be evolutionary selected. Such a
strong survival value could have the 10/G4 VH12 H chain
gene and its L chain partner, Vk4/5H, expressed as a sine
qua non component of the B-1 repertoire in mice and
other species.913 Tatu et al.
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